Stryker Corporation logo
Stryker Corporation (SYK)
Compare

SYK Balance Sheet

Assets, liabilities, and equity analysis

SYK Quarterly Balance Sheet (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
Total Current Assets
13.338B13.338B14.755B13.711B13.003B13.022B14.847B14.673B11.645B
2.878B2.878B4.011B3.256B2.375B2.320B3.652B3.850B1.874B
Short-Term Investments
87.000M87.000M89.000M87.000M89.000M89.000M841.000M834.000M83.000M
Cash & Short-Term Investments
2.965B2.965B4.100B3.343B2.464B2.409B4.493B4.684B1.957B
3.571B3.571B4.039B3.643B3.918B3.961B3.987B3.736B3.622B
5.419B5.419B5.310B5.370B5.289B5.105B4.774B5.292B5.044B
46.291B46.291B47.844B47.057B46.331B46.006B42.971B43.833B39.130B
4.416B4.416B4.395B3.734B4.253B4.106B3.964B3.945B3.828B
19.188B19.188B19.291B19.256B19.183B19.089B15.855B16.396B15.408B
Intangible Assets
5.516B5.516B5.681B5.845B5.962B6.132B4.395B4.940B4.363B
Long-Term Investments
82.000M82.000M2.000M44.000M3.000M8.000M39.000M1.000M16.000M
Total Current Liabilities
6.315B6.315B7.794B7.414B7.288B7.929B7.616B7.669B6.926B
1.592B1.592B1.799B1.498B1.442B1.464B1.679B1.337B1.304B
660.000M660.000M1.153B1.911B1.910B2.559B1.553B2.308B2.238B
Total Liabilities
23.312B23.312B25.424B25.272B25.140B25.076B22.337B23.684B19.368B
14.224B14.224B14.859B15.222B14.829B14.383B12.188B13.325B10.127B
15.234B15.234B16.360B17.510B17.128B17.356B14.120B16.007B12.744B
Net Debt (Cash)
12.356B12.356B12.349B14.254B14.753B15.036B10.468B12.157B10.870B
22.979B22.979B22.420B21.785B21.191B20.930B20.634B20.149B19.762B
Common Stock
38.000M38.000M38.000M38.000M38.000M38.000M38.000M38.000M38.000M
20.878B20.878B20.472B19.960B19.423B18.862B18.528B18.303B17.774B
2.112.111.891.851.781.641.951.911.68
0.660.660.730.800.810.830.680.790.64

SYK Annual Balance Sheet (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Current Assets
14.755B14.847B12.518B10.275B10.017B9.707B11.360B9.733B
4.011B3.652B2.971B1.844B2.944B2.943B4.337B3.616B
Short-Term Investments
89.000M841.000M82.000M84.000M75.000M81.000M88.000M83.000M
Cash & Short-Term Investments
4.100B4.493B3.053B1.928B3.019B3.024B4.425B3.699B
4.039B3.987B3.765B3.565B3.022B2.701B2.893B2.332B
5.310B4.774B4.843B3.995B3.314B3.494B3.282B2.955B
47.844B42.971B39.912B36.884B34.631B34.330B30.167B27.229B
4.395B3.964B3.709B3.443B3.252B3.175B2.951B2.291B
19.291B15.855B15.243B14.880B12.918B12.778B9.069B8.563B
Intangible Assets
5.681B4.395B4.593B4.885B4.840B5.554B4.227B4.163B
Long-Term Investments
2.000M39.000M2.000M90.000M66.000M4.000M0.000.00
Total Current Liabilities
7.794B7.616B7.921B6.303B4.549B5.041B4.400B4.807B
1.799B1.679B1.517B1.413B1.129B810.000M675.000M646.000M
1.153B1.553B2.237B1.312B119.000M870.000M945.000M1.373B
Total Liabilities
25.424B22.337B21.319B20.268B19.754B21.246B17.360B15.499B
14.859B12.188B10.901B11.857B12.472B13.230B10.231B8.486B
16.360B14.120B13.494B13.526B12.901B14.425B11.477B9.859B
Net Debt (Cash)
12.349B10.468B10.523B11.682B9.957B11.482B7.140B6.243B
22.420B20.634B18.593B16.616B14.877B13.084B12.807B11.730B
Common Stock
38.000M38.000M38.000M38.000M38.000M38.000M37.000M37.000M
20.472B18.528B16.771B14.765B13.480B12.462B11.748B10.765B
1.891.951.581.632.201.932.582.02
0.730.680.730.810.871.100.900.84

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Portage, MI
53,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin A. Lobo